Synthetic studies on ecteinascidin-743: Constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins

Organic Letters

Volumn 5, Issue 12, 2003, Pages 2095-2098

  Jin, Wei ^a   Metobo, Sammy ^a   Williams, Robert M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECTEINASCIDIN 743; SAFRAMYCIN A; SAFRAMYCIN B; TETRAHYDROISOQUINOLINE DERIVATIVE;

ARTICLE; ASYMMETRIC SYNTHESIS; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DIOXOLES; ISOQUINOLINES; MODELS, MOLECULAR; STEREOISOMERISM; TETRAHYDROISOQUINOLINES; UROCHORDATA;

EID: 0141519496     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol034575n     Document Type: Article

References (31)

1. (a) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Keifer, P. A.; Wilson, G. R.; Perun, T. J.; Sakai, R.; Thompson, A. G.; Stroh, J. G.; Shield, L. S.; Seigler, D. S. J. Nat. Prod. 1990, 53, 771-792.
2. (b) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, L. H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512-4515.
3. (c) Wright, A. E.; Forleo, D. A.; Gunawardana, G. P.; Gunasekera, S. P.; Koehn, F. E.; McConnell, O. J. J. Org. Chem. 1990, 55, 4508-4512.
4. (d) Guan, Y.; Sakai, R.; Rinehart, K. L.; Wang, A. H.-J. J. Biomol. Struct. Dyn. 1993, 10, 793-818.
5. (a) Zelek, L.; Yovine, A.; Etienne, B.; Jimeno, J.; Taamma, A.; Martín, C.; Spielmann, M.; Cvitkovic, E.; Misset, J. L. Ecteinacidin-743 in taxane/Antracycline pretreated advanced/metastatic breast cancer patients: preliminary results with the 24 h continuous infusion Q3 week schedule, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, May 20-23, 2000; Abstract number 592.
6. (b) Delaloge, S.; Yovine, A.; Taamma, A.; Cottu, P.; Riofrio, M.; Raymond, E.; Brain, E.; Marty, M.; Jimeno, J.; Cvitkovic, E.; Misset, J. L. Preliminary evidence of activity of Ecteinacidin-743 (ET-743) in heavily pretreated patients with bone and soft tissue sarcomas, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, May 20-23, 2000; Abstract number 2181.
7. (c) Le Cesne, A.; Judson, I.; Blay, J. Y.; Radford, J.; an Oosterom, A.; Lorigan, P.; Rodenhuis, E.; Donato Di Paoula, E.; Van Glabbeke, M.; Jimeno, J.; Verweij, J. Phase II of ET-743 in advance soft tissue sarcoma in adult: a STBSG-EORTC trial, presented at the American Society of Clinical Oncology, 36th Annual Meeting, New Orleans, May 20-23, 2000; Abstract number 2182.
8. (d) Aune G. J.; Furuta T.; Pommier Y. Anti-Cancer Drugs 2002, 13, 545-555.
9. (a) Jin, S.; Gorfajn, B.; Faircloth, G.; Scotto, K. W. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6775-6779
10. (b) Minuzzo, M.; Marchini, S.; Broggini, M.; Faircloth, G.; D'Incalci, M.; Mantovani, R. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6780-6784.
11. Corey, E. J.; Gin, D. Y.; Kania, R. J. Am. Chem. Soc. 1996, 118, 9202-9203.
12. Martinez, E. J.; Owa, T.; Schreiber, S. L.; Corey, E. J. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3496-3501.
13. Cuevas, C.; Pérez, M.; Martín, M. J.; Chicharro, J. L.; Fernández-Rivas, C.; Flores, M.; Francesch, A.; Gallego, P.; Zarzuelo, M.; de la Calle, F.; García, J.; Polanco, C.; Rodríguez, I.; Manzanares, I. Org. Lett. 2000, 16, 2545-2548.
14. Endo, A.; Yanagisawa, A.; Abe, M.; Tohma, S.; Kan, T.; Fukuyama, T, J. Am. Chem. Soc. 2002, 124, 6552-6554.
15. (a) Ikeda, Y.; Idemoto, H.; Hirayama, F.; Yamamoto, K.; Iwao, K.; Asao, T.; Munakata, T. J. Antibiot. 1983, 36, 1279-1283.
16. (b) Ikeda, Y.; Matsuki, H.; Ogawa, T.; Munakata, T. J. Antibiot. 1983, 36, 1284-1289.
17. Arai, T.; Takahashi, K.; Kubo, A.; Nakahara, S. Experientia 1980, 36, 1025-1026.
18. (a) Frincke, J. M.; Faulkner, D. J. J. Am. Chem. Soc. 1982, 104, 265-269.
19. (b) He, H.; Faulkner, D. J. J. Org. Chem. 1989, 54, 5822-5824.
20. (c) Davidson, B. S. Tetrahedron Lett. 1992, 33, 3721-3724.
21. (d) Parameswaran, P. S.; Naik, C. G.; Kamat, S. Y.; Pramanik, B. N. Ind. J. Chem. 1998, 37B, 1258-1263.
22. (e) Fontana, A.; Cavaliere, P.; Wahidulla, S.; Naik, C. G.; Cimino, G. Tetrahedron 2000, 56, 7305-7308.
23. Herberich B.; Kinugawa M.; Vazquez A.; Williams, R. M. Tetrahedron Lett. 2001, 42, 543-546.
24. Jin, W.; Williams, R. M. Unpublished results.
25. Matsui, S.; Hashimoto, Y.; Sago, K. Synthesis 1998, 1161-1166.
26. It should be noted that the free phenol was found to be essential for a successful Pictet-Spengler cyclization reaction to proceed. Related substrates containing the methylenedioxy moiety or simple aryl methyl ethers failed to afford the corresponding Pictet-Spengler products.
27. 1H NMR data of the pre-Pictet-Spengler β-lactam used to prepare i to that of 21 was used to establish the relative stereochemistry of 21.
28. The coupling with the acid chloride 18 in the presence of DMAP did not lead to detectable racemization.
29. A search of the literature did not reveal any general methods for the reduction of β-lactams to aldehydes. For a pertinent reference, see: Ojima, I.; Zhao, M.; Yamato, T.; Nakahashi, K.; Yamashita, M.; Abe, R. J. Org. Chem. 1991, 56, 5263-5277.
30. 1H NMR nOe studies.
31. All new compounds gave satisfactory spectroscopic and analytical data consistent with the assigned structures (see Supporting Information).